Cytori Therapeutics Inc. (CYTX) Granted a Japanese Patent for Its Celution System Technology
Cytori Therapeutics Inc. is a leader in providing patients and physicians around the world with medical technologies that harness the potential of adult regenerative cells from adipose tissue. The company's Celution System family of medical devices and instruments is being sold into the European and Asian cosmetic and reconstructive surgery markets, but is not yet available in the US. The company announced today that it has been issued Patent No. 4653952 from the Japan Patent Office covering devices for extracting and concentrating the stem and regenerative cells which naturally exist within adipose tissue. Specifically, the patent covers the underlying technology…